Time dependent alterations of co-localization of S100β and GFAP in the MPTP-treated mice

Journal of Neural Transmission

Volumn 113, Issue 12, 2006, Pages 1887-1894

  Himeda, T ^a   Watanabe, Y ^a   Tounai, H ^a   Hayakawa, N ^a   Kato, H ^b   Araki, T ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Astrocytes; GFAP; Immunohistochemistry; MPTP; S100 ; Striatum

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S100B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CELL ACTIVATION; CELL SUBPOPULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

ANIMALS; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NEOSTRIATUM; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEUROGLIA; S100 PROTEINS; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 33750974801     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0482-x     Document Type: Article

References (39)

1. B Ahlemeyer H Beier I Semkova C Schaper J Krieglstein 2000 S-100β protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay × 3702 Brain Res 858 121 128
2. T Araki T Kumagai K Tanaka M Matsubara H Kato Y Itoyama Y Imai 2001 Neuroprotective effect of riluzole in MPTP-treated mice Brain Res 918 176 181
3. BR Bloem I Irwin OJ Buruma J Haan RA Roos JW Tetrud JW Langston 1990 The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease J Neurol Sci 97 273 293
4. + Free Radic Biol Med 13 581 583
5. CC Chiueh P Rauhala 1998 Free radicals and MPTP-induced selective destruction of substantia nigra compacta neurons Adv Pharmacol 42 796 800
6. R Donato 2001 S100: a multigenic family of calcium-modulated proteins of EF-hand type with intracellular and extracellular functional roles Int J Biochem Cell Biol 33 637 668
7. WS Griffin LC Stanley C Ling L White V MacLeod LJ Perrot C White C Araoz 1989 Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease Proc Natl Acad Sci USA 86 7611 7615
8. P Hantraye M Varastet M Peschanski D Riche P Cesaro JC Willer M Maziere 1993 Stable Parkinsonian syndrome and uneven loss of striatal dopamine fibers following chronic MPTP administration in baboons Neuroscience 53 169 178
9. +) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles Biochem Biophys Res Commun 170 1049 1055
10. RE Heikkila L Manzino FS Cabbat RC Duvoisin 1984 Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors Nature 311 467 469
11. CW Heizmann 1992 Calcium-binding proteins: basic concepts and clinical implications Gen Physiol Biophys 11 411 425
12. T Himeda N Hayakawa H Tounai M Sakuma H Kato T Araki 2005 Alterations of interneurons of the gerbil hippocampus after transient cerebral ischemia: effect of pitavastatin Neuropsychopharmacology 30 2014 2025
13. O Hornykiewicz 1966 Dopamine (3-hydroxytyramine) and brain function Pharmacol Rev 18 925 964
14. O Hornykiewicz SJ Kish 1987 Biochemical pathophysiology of Parkinson's disease Adv Neurol 45 19 34
15. J Hu A Ferreira LJ Van Eldik 1997 S100β induces neuronal cell death through nitric oxide release from astrocytes J Neurochem 69 2294 2301
16. H Kato K Kogure T Araki Y Itoyama 1995 Graded expression of immunomolecules on activated microglia in the hippocampus following ischemia in a rat model of ischemic tolerance Brain Res 694 85 93
17. SJ Kish K Shannak O Hornykiewicz 1988 Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications N Eng J Med 318 876 880
18. R Kurosaki Y Muramatsu Y Imai H Kato T Araki 2004 Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice Neurol Res 26 644 657
19. RC Lin K Polsky DF Matesic 1993 Expression of gamma-aminobutyric acid immunoreactivity in reactive astrocytes after ischemia-induced injury in the adult forebrain Brain Res 600 1 8
20. T Matsui T Mori N Tateishi Y Kagamiishi S Satoh N Katsube E Morikawa T Morimoto F Ikuta T Asano 2002 Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats: Part I: enhanced astrocytic synthesis of s-100beta in the periinfarct area precedes delayed infarct expansion J Cereb Blood Flow Metab 22 711 722
21. A Migheli S Cordera C Bendotti C Atzori R Piva D Schiffer 1999 S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis Neurosci Lett 261 25 28
22. Y Muramatsu R Kurosaki H Watanabe M Michimata M Matsubara Y Imai T Araki 2003 Expression of S-100 protein is related to neuronal damage in MPTP-treated mice Glia 42 307 313
23. Y Muramatsu R Kurosaki H Kato T Araki 2004 Effect of pitavastatin against expression of S100beta protein in the gerbil hippocampus after transient cerebral ischemia Acta Physiol Scand 182 95 107
24. S Nakamura I Akiguchi J Kimura 1993 The histochemical demonstration of MPTP oxidation in the postmortem human striatum Neurosci Lett 154 61 64
25. JP O'Callaghan DB Miller JF Reinhard Jr 1990 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP Neurosci Lett 117 228 233
26. A Regner M Kaufman G Friedman I Chemale 2001 Increased serum S100β protein concentrations following severe head injury in humans: a biochemical marker of brain death? Neuroreport 12 691 694
27. M Romero-Alemán Mdel M Monzón-Mayor C Yanes JF Arbelo-Galván D Lang J Renau-Piqueras C Negrín-Martínez 2003 S100 immunoreactive glial cells in the forebrain and midbrain of the lizard Gallotia galloti during ontogeny J Neurobiol 57 54 66
28. BW Schäfer CW Heizmann 1996 The S100 family of EF-hand calcium-binding proteins: functions and pathology Trends Biochem Sci 21 134 140
29. RH Selinfreund SW Barger WJ Pledger LJ Van Eldik 1991 Neurotrophic protein S100beta stimulates glial cell proliferation Proc Natl Acad Sci USA 88 3554 3558
30. JG Sheng RE Mrak WS Griffin 1997 Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100bata+ astrocytes with neurofibrillary tangle stage J Neuropathol Exp Neurol 56 285 290
31. K Sriram KS Pai MR Boyd V Ravindranath 1997 Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice Brain Res 749 44 52
32. N Tateishi T Mori Y Kagamiishi S Satoh N Katsube E Morikawa T Morimoto T Matsui T Asano 2002 Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits J Cereb Blood Flow Metab 22 723 734
33. KF Tipton TP Singer 1993 Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds J Neurochem 61 1191 1206
34. L Turski K Bressler KJ Rettig PA Loschmann H Wachtel 1991 Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists Nature 349 414 418
35. LJ Van Eldik B Ehrenfried RA Jensen 1984 Production and characterization of monoclonal antibodies with specificity for the S100beta polypeptide of brain S100 fractions Proc Natl Acad Sci USA 81 6034 6038
36. H Watanabe Y Muramatsu R Kurosaki M Michimata M Matsubara Y Imai T Araki 2004 Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study Eur Neuropsychopharmacol 14 93 104
37. PM Whitaker-Azmitia M Wingate A Borella R Gerlai J Roder EC Azmitia 1997 Transgenic mice overexpressing the neurotrophic factor S-100beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome Brain Res 776 51 60
38. MD Yahr 1993 Parkinson's disease. The L-dopa era Adv Neurol 60 11 17
39. DB Zimmer EH Cornwall A Landar W Song 1995 The S100 protein family: history, function, and expression Brain Res Bull 37 417 429